Aramco CEO Amin Nasser on the Future of Oil, AI & Saudi Vision 2030 (Extended Intervierw)

Posted Jun 21 by Two Blokes

Saudi Aramco CEO Amin Nasser opens up about Aramco's multi-billion dollar investments in artificial intelligen

Source: Two Blokes Trading

CIVI DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Civitas Resources, Inc. Investors to Secure Counsel Before Important J

Posted Jun 21 by Two Blokes

NEW YORK, June 21, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds pu

Source: Two Blokes Trading

Gan & Lee Pharmaceuticals Presented Multiple Results in Novel Diabetes Therapies at the American Diabetes Association's 85th Sci

Posted Jun 21 by Two Blokes

In a Phase 2a clinical trial, the GLP-1 RA bofanglutide injection demonstrated a favorable safety and tolerabi

Source: Two Blokes Trading

Perspective Therapeutics Commences Recruitment for [212Pb]VMT-α-NET in the Third Dose Escalation Cohort of its Ongoing Phase 1/2

Posted Jun 21 by Two Blokes

SEATTLE, June 21, 2025 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. ("Perspective" or the "Company") (NY

Source: Two Blokes Trading

ROSEN, LEADING INVESTOR COUNSEL, Encourages Red Cat Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Secu

Posted Jun 21 by Two Blokes

NEW YORK, June 21, 2025 (GLOBE NEWSWIRE) -- WHY: New York, N.Y., June 21, 2025. Rosen Law Firm, a global inves

Source: Two Blokes Trading

ROSEN, LEADING INVESTOR COUNSEL, Encourages Reddit, Inc. Investors to Secure Counsel Before Important Deadline in Securities Cla

Posted Jun 21 by Two Blokes

NEW YORK, June 21, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces

Source: Two Blokes Trading

MetaVia Presents Pre-Clinical Data on DA-1241 Demonstrating Additive Hepatoprotective Effects in Combination With Efruxifermin a

Posted Jun 21 by Two Blokes

CAMBRIDGE, Mass. , June 21, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology c

Source: Two Blokes Trading

Lilly's oral GLP-1, orforglipron, showed compelling efficacy and a safety profile consistent with injectable GLP-1 medicines, in

Posted Jun 21 by Two Blokes

The investigational once-daily pill  lowered A1C by an average of 1.3% to 1.6% across doses, with improvements

Source: Two Blokes Trading

INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Tempus AI, Inc. Investors with Substantial Losses Have Opportun

Posted Jun 21 by Two Blokes

SAN DIEGO, June 21, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that p

Source: Two Blokes Trading

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages PepGen Inc. Investors to Secure Counsel Before Important Deadline in Securities Cla

Posted Jun 21 by Two Blokes

NEW YORK, June 21, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds pu

Source: Two Blokes Trading

Giyani Metals secures up $225M loan from EXIM - ICYMI

Posted Jun 21 by Two Blokes

Giyani Metals Corp (TSX-V:EMM, OTC:CATPF) CEO Charles FitzRoy talked with Proactive about the company's recent

Source: Two Blokes Trading

Gan & Lee Pharmaceuticals Presented Multiple Results in Novel Diabetes Therapies at the American Diabetes Association's 85th Sci

Posted Jun 21 by Two Blokes

In a Phase 2a clinical trial, the GLP-1 RA bofanglutide injection demonstrated a favorable safety and tolerabi

Source: Two Blokes Trading